Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06562296 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
A Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Cellution Biologics.
- Active
- Registry status
- Phase 4
- Development phase
- 292
- Enrollment target
- 4
- Study locations
NCT06562296 is a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer that is active but no longer recruiting, run by Cellution Biologics. The registered enrollment target is 292 participants, above the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (16% higher). The trial reports 4 study locations across 4 states.
The verdict
NCT06562296, a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, is active but no longer recruiting, sponsored by Cellution Biologics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 292 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot and venous leg ulcers.
Conditions Studied
Interventions
- OTHER Amnion-Intermediate-Chorion
- PROCEDURE Standard of Care
- OTHER Amnion-Chorion-Amnion
Study Locations (4)
Florida
- Symphony Research - Jacksonville
Ohio
- Sure Step Foot & Ankle - Cincinnati
Texas
- RGV Wound Care Group - Weslaco
Wisconsin
- Family Foot & Ankle - Kenosha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2025-12-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06562296
The ClinicalTrials.gov registry entry for NCT06562296 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (16% higher). The listed sponsor is Cellution Biologics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 3 interventions - of which Amnion-Intermediate-Chorion is the first listed.
NCT06562296 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT06562296 about?
NCT06562296 is a clinical study titled "Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers". The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot and venous leg ulcers.
What is the current status of trial NCT06562296?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 292 participants. The study started on 2024-10-14. Estimated completion is 2025-12-25.
What conditions does trial NCT06562296 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer.
What interventions are being tested in trial NCT06562296?
The interventions under investigation include: Amnion-Intermediate-Chorion (OTHER), Standard of Care (PROCEDURE), Amnion-Chorion-Amnion (OTHER).
Who is sponsoring clinical trial NCT06562296?
This trial is sponsored by Cellution Biologics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06562296 being conducted?
This trial has 4 study locations across Florida, Ohio, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.